_____________
Snapshot overview: Aims to accelerate the clinical development of new or improved medicinal products for prevention of poverty-related and neglected infectious diseases
_____________
Name: European and Developing Countries Clinical Trials Partnership Programme (EDCTP3)
_____________
Institution/ DG/ Agency responsible at EU-level: European Innovation Council (Horizon Europe)
_____________
Work programme: Open-ended funding with deadline (2027)
_____________
Programme: Partnership programmes
_____________
Programme budget: EUR 800 million
_____________
Project budget:EUR 4 million
_____________
Type of funding : Predominately bottom-up, but challenge driven funding available
_____________
Target participants: Aims to involve researchers and organisations based in Africa
_____________
Programme scope: Infectious diseases, such as HIV, malaria and Tuberculosis, but also other poverty related and neglected infectious diseases, with a focus on Africa, especially in sub-Saharan Africa. Covers emerging infectious diseases threats, antimicrobial resistance and non-communicable diseases co-morbidities.
_____________
Participant criteria: Funding from the Global Health EDCTP3 Joint Undertaking shall be restricted to entities eligible for funding under the Horizon Europe programme and established in the constituent states of the EDCTP Association.
_____________
Project duration: Duration of Horizon Europe (2021-2027)
_____________
Average time from submission to project kick-off: Currently unknown
_____________
R&D stage: Early-stage research and development
_____________
Intellectual property: TBD
_____________
Project database: EEU Funding & Tender Opportunities portal – Single Electronic Data Interchange Area (SEDIA)
_____________
Status: Calls for application has opened on 11 May 2022. The deadline is on 30 August 2022
_____________
Contact details & more information:
